Global Gastrointestinal Stromal Tumors Market – Overview
One of the most common form of sarcoma is gastrointestinal stromal tumors (GIST) involving the gastrointestinal tract. Gastrointestinal stromal tumors can occur anyplace within the GI tract but is most often found in the stomach i.e. about in 40-70% of the cases and 20-30% in the small intestine. Every year approximately 11 to 20 million people worldwide are diagnosed with GIST.
research report on “Gastrointestinal Stromal Tumors Market Research Report – Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
Bayer AG (Germany) Novartis AG (Switzerland), Immunicum AB (Sweden), F. Hoffmann-La Roche Ltd.(Switzerland), AB SCIENCES (FRANCE), Arog Pharmaceuticals, Inc. (U.S), Boston Biomedical, Inc. (U.S) are some of the prominent players at the forefront of competition in the Global Gastrointestinal Stromal Tumors Market and are profiled in MRFR Analysis.
The global gastrointestinal stromal tumors market segments on the basis of the indication, diagnosis, treatment, and end-user.
Global Gastrointestinal Stromal Tumors Market – Regional Analysis
Global gastrointestinal stromal tumors market is segmented on the basis of geographies or regions which mainly includes North America, Europe, Asia Pacific, and Middle East & Africa. North America is dominating the global market for gastrointestinal stromal tumors with more than 35% share of the total market in 2016. The major factor for the growth of the market include due to increasing prevalence of liver cancer. According to Centers for Disease Control and Preventation, every year in the U.S. about 22,000 men & 9,000 women get liver cancer, and more than 16,000 men & 8,000 women die from the same disease. The percentage of Americans who develop liver cancer has been rising from past few decades. More over the presence of major manufacturers in the region and the development for the products has been influencing the growth of the market.
Europe holds the second largest share of the global gastrointestinal stromal tumors market. Asia Pacific is the fastest growing gastrointestinal stromal tumors stimulation market across the globe. In Asia-Pacific there is wide range of opportunities for gastrointestinal stromal tumors market due to the presence of developing countries, major companies are grabbing these opportunities and expanding their presence in the region. Furthermore increasing research and development in this region has further enhanced the growth of the market.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
The Gastrointestinal Stromal Tumors Market size is forecasted to demonstrate a same growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2023.
There has been increasing development in the field of Gastrointestinal Stromal Tumors. Companies are keen in developing new products for the same. In November 2016, announced supplemental New Drug Application (sNDA) for Stivarga tablets had been submitted for the approval to the U.S. Food and Drug Administration (FDA) for the second-line systemic treatment of patients with unresectable hepatocellular carcinoma (uHCC). Hepatocellular carcinoma (HCC), is the most common form of liver cancer accounting for more than 70-85 percent of liver cancer across the world.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: [email protected]
The Business Research Company published its Gastrointestinal Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Gastrointestinal Drugs market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the gastrointestinal drugs market’s segments- 1) By Type: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others3) By Route Of Administration: Oral, Parenteral, Others4) By Drug Classification: Branded Drugs, Generic Drugs5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
View Complete Report:https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2020-30-covid-19-implications-and-growthGastrointestinal Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global gastrointestinal drugs market is expected to grow from $42.8 billion in 2019 to $48.5 billion in 2020 at a compound annual growth rate (CAGR) of 13.4%.
The growth is mainly due to the impact of COVID-19 on the digestive system.
Report on World Gastrointestinal Endoscopic Devices Market by Product Type, Market, Players and Regions-Forecast to 2025 by DecisionDatabases.comGastrointestinal Endoscopic Devices market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/47946-world-gastrointestinal-endoscopic-devices-market-reportThe Players mentioned in our reportOlympusJohnson & JohnsonMedtronicColoplastCONMEDFujifilm HoldingsKARL STORZRicohGI DynamicsGlobal Gastrointestinal Endoscopic Devices Market: Application Segment AnalysisGlobal Gastrointestinal Endoscopic Devices Market: Regional Segment AnalysisUSAEuropeJapanChinaIndiaDownload Free Sample Report of World Gastrointestinal Endoscopic Devices Market @ https://www.decisiondatabases.com/contact/download-sample-47946There are 10 Chapters to deeply display the World Gastrointestinal Endoscopic Devices market.Chapter 1 About the Gastrointestinal Endoscopic Devices IndustryChapter 2 World Market Competition LandscapeChapter 3 World Gastrointestinal Endoscopic Devices Market shareChapter 4 Supply Chain AnalysisChapter 5 Company ProfilesChapter 6 Globalisation & TradeChapter 7 Distributors and CustomersChapter 8 Import, Export, Consumption and Consumption Value by Major CountriesChapter 9 World Gastrointestinal Endoscopic Devices Market Forecast through 2025Chapter 10 Key success factors and Market OverviewPurchase the complete World Gastrointestinal Endoscopic Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-47946Other Reports by DecisionDatabases.com:World External Beam Radiation Therapy Devices Market Research Report 2022 (covering USA, Europe, China, Japan, India, South East Asia and etc)World Biopsy Devices for Cancer Market Research Report 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
